Answers are grounded in this paper and cite their sources.
Precision medicine in paediatric cardiac channelopathy and cardiomyopathy has a rapid advancement over the past years. Compared to conventional gene panel and exome-based testing, whole genome sequencing (WGS) offers additional coverage at the promoter, intronic regions and the mitochondrial genome. However, the data on use of WGS to evaluate the genetic cause of these cardiovascular conditions in children and adolescents are limited.
No takes yet. Share an insight, caveat, or question.
Kwok et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: